M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Magenta Therapeutics, Inc. to acquire Dianthus Therapeutics
Announced May 3, 2023 · Closed Sep 12, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Magenta Therapeutics, Inc. (MGTA)
- Target
- Dianthus Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Sep 12, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Wedbush, Houlihan Lokey
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations